-
摘要:
目的 探讨影响结直肠癌腹膜种植转移的临床病理相关因素。 方法 收集2005年1月至2009年12月广西医科大学第一附属医院的结直肠癌患者1 170例的临床病理资料, 研究结直肠癌腹膜种植转移与临床病理因素的关系。采用非条件Logistic回归单因素分析, 并对有统计学意义的变量进行非条件Logistic回归多因素分析。 结果 1 170例结直肠癌患者中, 腹膜种植转移92例(7.86%)。单因素分析显示, 患者的年龄、肿瘤部位、浸润肠腔周径、肿瘤最大径、组织病理学类型、分化程度、肠壁浸润深度、淋巴结转移和血CEA水平与结直肠癌腹膜转移有关。Logistic多因素分析显示, 肿瘤部位、浸润肠腔周径、分化程度、肠壁浸润深度、淋巴结转移和血CEA水平与结直肠癌腹膜转移的有关。 结论 肿瘤部位、浸润肠腔周径、分化程度、肠壁浸润深度、淋巴结转移和血CEA水平是结直肠癌发生腹膜转移的独立相关因素。 Abstract:Objective This study aims to investigate the clinicopathologic factors related to peritoneal metastasis in 1170 colorectal cancer patients. Methods Clinicopathologic data from 1170 colorectal cancer patients treated in The First Affiliated Hospital, Guangxi Medical University between January 2005 and December 2009 were collected.The associations between peritoneal metastasis and clinicopathological factors were evaluated by univariate and multivariate logistic regression analyses.All analyses were conducted using SPSS software(version 13.0). Results Of the 1170 cases, 92(7.86%) had peritoneal metastases.Univariate analysis showed that age, tumor location, tumor size(cm), tumor circumference, histological type, tumor differentiation, invasion depth, lymph node metastasis, and serum carcinoembryonic antigen(CEA) levels were predictors that could affect peritoneal metastasis.Multivariate analysis showed that tumor location, tumor circumference, tumor differentiation, invasion depth, lymph node metastasis, and serum CEA levels were independent factors related to peritoneal metastasis from colorectal cancer. Conclusion Tumor location, tumor circumference, tumor differentiation, invasion depth, lymph node metastasis, and serum CEA levels were clinicopathologic factors related to peritoneal metastasis from colorectal carcinoma. -
Key words:
- colorectal neoplasm /
- peritoneal metastasis /
- univariate analysis /
- multivariate analysis
-
表 1 1170例结直肠癌腹膜转移患者的临床病理特征单因素分析
Table 1. Logistic univariate regression analysis of peritoneal metastasis in 1170 colorectal cancer cases
表 2 1 170例结直肠癌腹膜转移患者的临床病理特征多因素分析
Table 2. Logistic multivariate regression analysis of peritoneal metastasis in 1 170 colorectal cancer cases
-
[1] Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CACancer J Clin, 2011, 61(2): 69-90. doi: 10.3322/caac.20107 [2] Cunningham D, Atkin W, Lenz HJ, et al. Colorectal cancer[J]. Lancet, 2010, 375(9719): 1030-1047. doi: 10.1016/S0140-6736(10)60353-4 [3] Koppe MJ, Boerman OC, Oyen WJ, et al. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies[J]. Ann Surg, 2006, 243(2): 212-222. doi: 10.1097/01.sla.0000197702.46394.16 [4] Segelman J, Granath F, Holm T, et al. Incidence, prevalence andrisk factors for peritoneal carcinomatosis from colorectal cancer[J]. Br J Surg, 2012, 99(5): 699-705. doi: 10.1002/bjs.8679 [5] Jayne DG, Fook S, Loi C, et al. Peritoneal carcinomatosis fromcolorectal cancer[J]. Br J Surg, 2002, 89(12): 1545-1550. doi: 10.1046/j.1365-2168.2002.02274.x [6] 晏仲舒. 对待腹膜肿瘤种植转移的新概念[J]. 中国普通外科杂志, 2006, 15(10): 801-802. doi: 10.3969/j.issn.1005-6947.2006.10.021 [7] Gomez-Portilla A, Cendoya I, Lopez de Tejada I, et al. Principlesof the treatment of peritoneal carcinomatosis due to colorectal cancer. Current review and update[J]. Cir Esp, 2005, 77(1): 6-17. doi: 10.1016/S0009-739X(05)70796-X [8] Lemmens VE, Klaver YL, Verwaal VJ, et al. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: apopulation-based study[J]. Int J Cancer, 2011, 128(11): 2717-2725. doi: 10.1002/ijc.25596 [9] 刘峰, 余江, 梁耀泽, 等. 结直肠癌腹膜种植转移的危险因素分析[J]. 中华胃肠外科杂志, 2011, 14(4): 254-256. doi: 10.3760/cma.j.issn.1671-0274.2011.04.007 [10] 宋武, 何裕隆, 蔡世荣, 等. 结直肠癌伴腹膜扩散的临床病理分析及手术干预对预后的影响[J]. 中华外科杂志, 2008, 46(21): 1634-1637. doi: 10.3321/j.issn:0529-5815.2008.21.011 [11] Sjo OH, Berg M, Merok MA, et al. Peritoneal carcinomatosis of colon cancer origin: highest incidence in women and in patients withright-sided tumors[J]. J Surg Oncol, 2011, 104(7): 792-797. doi: 10.1002/jso.21959 [12] Glebov OK, Rodriguez LM, Nakahara K, et al. Distinguishing rightfrom left colon by the pattern of gene expression[J]. Cancer Epidemiol Biomarkers Prev, 2003, 12(8): 755-762. [13] Meguid RA, Slidell MB, Wolfgang CL, et al. Is there a difference insurvival between right-versus left-sided colon cancers[J]AnnSurg Oncol, 2008, 15(9): 2388-2394. [14] Raftopoulos I, Davaris P, Karatzas G, et al. Level of alpha-cateninexpression in colorectal cancer correlates with invasiveness, metastatic potential, and survival[J]. J Surg Oncol, 1998, 68(2): 92-99. doi: 10.1002/(SICI)1096-9098(199806)68:2<92::AID-JSO4>3.0.CO;2-F [15] Filiz AI, Senol Z, Sucullu I, et al. The survival effect of E-cadherinand catenins in colorectal carcinomas[J]. Colorectal Dis, 2010, 12(12): 1223-1230. doi: 10.1111/j.1463-1318.2009.01994.x [16] Aresu L, Pregel P, Zanetti R, et al. E-cadherin and beta-catenin expression in canine colorectal adenocarcinoma[J]. Res Vet Sci, 2010, 89(3): 409-414. doi: 10.1016/j.rvsc.2010.04.008 [17] Ceelen WP, Bracke ME. Peritoneal minimal residual disease incolorectal cancer: mechanisms, prevention, and treatment[J]. LancetOncol, 2009, 10(1): 72-79. [18] Matsuda K, Hotta T, Takifuji K, et al. Lymph nodes ratio is associated with the survival of colorectal cancer patients with peritonealcarcinomatosis[J]. Am Surg, 2011, 77(5): 602-607. doi: 10.1177/000313481107700521 [19] Chua TC, Yan TD, Ng KM, et al. Significance of lymph node metastasis in patients with colorectal cancer peritoneal carcinomatosis[J]. World J Surg, 2009, 33(7): 1488-1494. doi: 10.1007/s00268-009-0059-6 [20] Reeder JA, Gotley DC, Walsh MD, et al. Expression of antisenseCD44 variant 6 inhibits colorectal tumor metastasis and tumorgrowth in a wound environment[J]. Cancer Res, 1998, 58(16): 3719-3726. [21] 荆结线, 杜丽莉, 王文达, 等. 结直肠癌患者血清肿瘤标志物水平与临床病理学特征的关系[J]. 中国肿瘤临床, 2008, 35(3): 162-166. doi: 10.3969/j.issn.1000-8179.2008.03.013
计量
- 文章访问数: 25
- HTML全文浏览量: 7
- PDF下载量: 6
- 被引次数: 0